Blood Transfusion Diagnostics Market Share

  • Report ID: 4481
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Regional Analysis:

North American Market Insights

North America industry is poised to account for largest revenue share of 41% by 2035. A higher number of road accidents taking place in the region is driving the market growth in North America. As of 2022, more than 6 million vehicle crashes took place in the United States. The growth is also attributed to the lack of blood during COVID-19, which in turn is propelling the requirement for blood donation. Since March 2020, the rate of blood donation dropped by about 10% and there has been about a 62% decrease in blood drives across colleges and schools.

APAC Market Insights

The Asia Pacific blood transfusion diagnostics market is projected to grow substantially till 2035. It is driven by aspects such as the rising need for blood transfusions, the developing healthcare infrastructure in the area, and the rising public awareness of the value of blood donation and testing. A considerable portion of the Asia Pacific blood transfusion diagnostics market is anticipated to increase in countries like China and India owing to their big populations and quickly growing healthcare infrastructure. Other countries in the area are also anticipated to develop as well due to factors such as the rise in hospital-based diagnostic labs and the desire for quick and precise blood tests.

Blood Transfusion Diagnostics Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood transfusion diagnostics is evaluated at USD 5.64 Billion.

The global blood transfusion diagnostics market size was worth more than USD 5.35 Billion in 2025 and is poised to witness a CAGR of over 6.1%, crossing USD 9.67 Billion revenue by 2035.

The North America blood transfusion diagnostics market will hold over 41% share by 2035, attributed to high accident rates and COVID-19 related blood supply disruptions.

Key players in the market include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos